Voices
Naveen Pemmaraju
Naveen Pemmaraju, Hannah Goular and Jayastu Senapati

Naveen Pemmaraju։ New Data on Adult Mixed Phenotype Acute Leukemia

Naveen Pemmaraju, Director of Leukemia-Cancer Network, Executive Director of Cancer Medicine, Director of BPDCN at the Department of Leukemia, and Professor at the Department of Leukemia at MD Anderson Cancer Center, shared a post on X about a recent paper she co-authored with colleagues published in JCO Precision Oncology:

“Our group’s paper now out in JCO Precision Oncology led by Hannah Goulart and Jayastu Senapati on patient outcomes with newly diagnosed MPAL.”

Title: Clinical Outcomes of Adult Patients With Newly Diagnosed Mixed Phenotype Acute Leukemia

Authors: Hannah Goulart, Farhad Ravandi, Nicholas J. Short, Nitin Jain, Naval Daver, Tapan M. Kadia, Courtney DiNardo, Gautam Borthakur, Koichi Takahashi, Naveen Pemmaraju, Fadi G. Haddad, Guillermo Montalban Bravo, Yesid Alvarado, Ghayas C. Issa, Alex Bataller, Sherry Pierce, Sanam Loghavi, Guilin Tang, Sa A. Wang, Beenu Thakral, Elizabeth Shpall, Richard Champlin, Issa Khouri, Partow Kebriaei, Guillermo Garcia-Manero, Koji Sasaki, Elias J. Jabbour, Jayastu Senapati

Read the Full Article in JCO Precision Oncology.

Naveen Pemmaraju։ New Data on Adult Mixed Phenotype Acute Leukemia

More posts featuring Naveen Pemmaraju.

Alex Bataller Beenu Thakral cancer Courtney DiNardo Elias J. Jabbour Elizabeth Shpall Fadi G. Haddad Farhad Ravandi Gautam Borthakur Ghayas C. Issa Guilin Tang Guillermo Garcia-Manero Guillermo Montalban-Bravo Hannah Goulart Issa Khouri Jayastu Senapati JCO Precision Oncology Koichi Takahashi Koji Sasaki MPAL Naval Daver Naveen Pemmaraju Nicholas J. Short Nitin Jain OncoDaily Oncology Partow Kebriaei Richard Champlin Sa A. Wang Sanam Loghavi Sherry Pierce Tapan M. Kadia Yesid Alvarado